Anzeige
Mehr »
Login
Donnerstag, 17.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
7 neue Bohrlöcher bei Best Chance: Gladiator Metals (WKN: A3D6HK) bereit für ein Ressourcen-Update
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
279 Leser
Artikel bewerten:
(1)

Oak View Bankshares, Inc. VA: Oak View Bankshares, Inc. Delivers Strong First Quarter Results

WARRENTON, VA / ACCESSWIRE / April 28, 2023 / Oak View Bankshares, Inc. (the "Company") (OTC Pink:OAKV), parent company of Oak View National Bank (the "Bank"), reported net income of $1.01 million for the quarter ended March 31, 2023, compared to net income of $596,779 for the quarter ended March 31, 2022. Basic and diluted earnings per share for the first quarter were $0.34 compared to $0.20 per share for the first quarter of 2022.

Selected Highlights:

  • Net Income of $1,013,086 for the quarter ended March 31, 2023, compared to $596,779 for the quarter ended March 31, 2022. This represents a 70% increase on a year-over-year basis.
  • Return on average assets was 0.76% and return on average equity was 14.03% for the quarter ended March 31, 2023, compared to 0.67% and 8.40%, respectively, for the quarter ended March 31, 2022.
  • Total assets were $537.38 million on March 31, 2023, compared to $497.99 million on December 31, 2022.
  • Total loans were $280.15 million on March 31, 2023, compared to $273.87 million on December 31, 2022.
  • Total securities were $226.02 million on March 31, 2023, compared to $193.31 million on December 31, 2022.
  • Total deposits were $455.92 million on March 31, 2023, compared to $422.90 million on December 31, 2022.
  • Regulatory capital remains strong with ratios exceeding the "well capitalized" thresholds in all categories.
  • Liquidity remains strong at $409.35 million as of March 31, 2023, compared to $377.86 million as of December 31, 2022. Liquidity includes cash, unencumbered securities available for sale, and available secured borrowing capacity.

Michael Ewing, Chairman of the Board and CEO said, "We value the relationships, both new and old, that we have established and are honored to be the trusted community bank for our shareholders, customers, and communities. We believe in Passionate Community Banking and our team of dedicated, knowledgeable, and experienced bankers provided exceptional service during a very challenging period for the banking industry. While many banks are experiencing liquidity concerns, the Company proved to be steadfast and strong." Mr. Ewing continued by saying, "Even though we did not need the funding, we used the recent crisis as an opportunity to test our liquidity strategy and were able to decisively validate that it is reliable. Our earnings performance resulted in a 70% increase over the quarter ended March 31, 2022, total deposits grew $33.02 million during the quarter and, we remain comfortably above regulatory thresholds for a well-capitalized bank. We manage the Company to seek the optimal balance among safety and soundness, profitability, and growth - in that order. Adherence to these straightforward principles has allowed us to stay strong and be prepared to meet the needs of our customers even in challenging times."

Net Interest Income

The net interest margin was 3.01% for the quarter ended March 31, 2023, compared to 3.12% for the quarter ended March 31, 2022. Net interest income was $3.82 million for the quarter ended March 31, 2023, compared to $2.62 million for the quarter ended March 31, 2022.

Interest income increased to $6.05 million for the quarter ended March 31, 2023, compared to $2.86 million for the quarter ended March 31, 2022. The primary contributor to the increase in interest income was the increase in interest on securities of $2.61 million compared to $158,344 for the quarter ended March 31, 2022. This income stream was the result of the Company's investment strategy that began over 18 months ago to deploy capital into securities with attractive risk and return characteristics.

Interest expenses were $2.23 million and $241,133 for the quarter ended March 31, 2023, and 2022, respectively. Increases in interest expense are primarily attributable to interest expense paid on deposits resulting from increases in volume and in interest rates and interest expense paid on FHLB advances and other borrowings due to higher balances needed to deploy capital into securities with attractive risk and return characteristics.

Noninterest Income

Noninterest income was $341,541 for the quarter ended March 31, 2023, compared to $296,254 for the quarter ended March 31, 2022. For the quarter ended March 31, 2023, the largest contributors of the increase in noninterest income compared to March 31, 2022, were debit card interchange fee income of $168,807, and income related to bank-owned life insurance of $62,409. Both increases are due, in large part, to increases in volume.

Noninterest income also included net gains on the sales of available for sale securities of $24,923 as of March 31, 2023. The sales of these investment securities were redeployed into assets with more attractive risk and return characteristics.

Noninterest Expense

Noninterest expense was $2.79 million for the quarter ended March 31, 2023, compared to $2.20 million for the quarter ended March 31, 2022.

Salaries and employee benefits were the largest category of noninterest expense, which totaled $1.73 million for the quarter, compared to $1.30 million for the quarter ended March 31, 2022. Salaries and employee benefits increased as of the quarter ended March 31, 2023, compared to the quarter ended March 31, 2022, as a result of newly added positions, the overall increase in employee benefits, including health insurance premiums and the increase in quarterly incentive compensation to all employees as a result of the Company's exceptional financial performance.

Liquidity

The Company's liquidity position was very strong with $409.35 million of liquid assets available which included cash, unencumbered securities available for sale, and secured borrowing capacity as of March 31, 2023, compared to $377.86 million as of December 31, 2022.

The Company is in a very strong position regarding the liquidity concerns facing the banking industry which were caused by the ability of large depositors to withdraw deposit balances that exceed the FDIC insurance limits. The Company had "uninsured" deposits of $93.64 million and $102.34 million, representing 22.54% and 24.02% of total deposits, on March 31, 2023, and December 31, 2022, respectively, well within industry averages. The Company's total available liquidity exceeded its uninsured deposits by over 400%, meaning that the Company had sufficient capacity to replace every uninsured dollar four times, thus assuring everyone's access to their money. The Company's deposit base proved to be stable as total deposits increased by $33.02 million for the quarter ended March 31, 2023.

Asset Quality

The Company adopted the recent accounting pronouncement for current expected credit losses ("CECL"), effective January 1, 2023. Prior to CECL's effective date, the Company accounted for the allowance for loan losses under the incurred loss model.

As of March 31, 2023, the allowance for credit losses related to the loan portfolio was $2.39 million or 0.85% of outstanding loans,net of unearned income, compared to $2.31 million or 0.84% of outstanding loans, net of unearned income, on December 31, 2022. On March 31, 2023, and December 31, 2022, there was one loan 90 or more days past due and still accruing interest, which totaled $18,345. This loan originated under the Small Business Administration ("SBA") Paycheck Protection Program and as of both reporting periods, the Company was awaiting payment of the 100% guarantee from the SBA. After March 31, 2023, the Company received this payment from the SBA.

Shareholders' Equity & Regulatory Capital

Shareholders' equity was $28.61 million on March 31, 2023, compared to $27.02 million on December 31, 2022. Accumulated Other Comprehensive Loss improved $1.01 million to $3.85 million as of March 31, 2023, compared to $4.86 million as of December 31, 2022, and is primarily related to unrealized losses in the available-for-sale securities portfolio which are attributable to mark-to-market adjustments resulting from rising interest rates.

As of March 31, 2023, the Bank's regulatory capital ratios were 13.70% in Common Equity Tier 1 and Tier 1 Capital, 14.48% in Total Capital and 8.65% in Leverage Ratio. These ratios exceeded the "well capitalized" thresholds for the period.

About Oak View Bankshares, Inc. and Oak View National Bank

Oak View Bankshares, Inc. is the parent bank holding company for Oak View National Bank, a locally owned and managed community bank serving Fauquier, Culpeper, Rappahannock, and surrounding Counties. For more information about Oak View Bankshares, Inc. and Oak View National Bank, please visit our website at www.oakviewbank.com. Member FDIC.

For additional information, contact Tammy Frazier, Executive Vice President & Chief Financial Officer, Oak View Bankshares, Inc., at 540-359-7155.

OTC Markets Group, Inc., Friday, April 28, 2023, Press release picture

OTC Markets Group, Inc., Friday, April 28, 2023, Press release picture

SOURCE: Oak View Bankshares, Inc.

View source version on accesswire.com:
https://www.accesswire.com/751868/Oak-View-Bankshares-Inc-Delivers-Strong-First-Quarter-Results

© 2023 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.